...
bblg-img

Bone Biologics Corp, Common Stock

BBLG

NAQ

$1.165

-$0.02

(-1.68%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.13M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
26.46K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.74
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.8 L
$6.34 H
$1.165

About Bone Biologics Corp, Common Stock

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameBBLGSectorS&P500
1-Week Return-0.83%-3.13%-0.02%
1-Month Return-9.85%-4.8%1.48%
3-Month Return4.39%-8.46%9.63%
6-Month Return-16.2%-2.88%13.17%
1-Year Return-66%6.92%31.56%
3-Year Return-99.87%4.63%30.19%
5-Year Return-99.95%42.11%93.4%
10-Year Return-100%103.49%198.28%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue50.00----[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit(50.00)----[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses2.45M825.01K1.10M3.67M9.43M[{"date":"2019-12-31","value":25.96,"profit":true},{"date":"2020-12-31","value":8.75,"profit":true},{"date":"2021-12-31","value":11.68,"profit":true},{"date":"2022-12-31","value":38.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(2.45M)(825.01K)(1.10M)(3.67M)(9.43M)[{"date":"2019-12-31","value":-244743400,"profit":false},{"date":"2020-12-31","value":-82501400,"profit":false},{"date":"2021-12-31","value":-110147600,"profit":false},{"date":"2022-12-31","value":-366517300,"profit":false},{"date":"2023-12-31","value":-942830300,"profit":false}]
Total Non-Operating Income/Expense(1.95M)(2.00M)(1.31M)1.45M(250.62K)[{"date":"2019-12-31","value":-134.7,"profit":false},{"date":"2020-12-31","value":-137.78,"profit":false},{"date":"2021-12-31","value":-90.6,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.3,"profit":false}]
Pre-Tax Income(3.42M)(1.82M)(1.61M)(1.48M)(8.95M)[{"date":"2019-12-31","value":-342320800,"profit":false},{"date":"2020-12-31","value":-182309000,"profit":false},{"date":"2021-12-31","value":-160908500,"profit":false},{"date":"2022-12-31","value":-148462000,"profit":false},{"date":"2023-12-31","value":-894873100,"profit":false}]
Income Taxes1.60K1.60K1.60K(2.18M)(2.18M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.81,"profit":true},{"date":"2021-12-31","value":99.81,"profit":true},{"date":"2022-12-31","value":-136029.51,"profit":false},{"date":"2023-12-31","value":-136029.51,"profit":false}]
Income After Taxes(3.42M)(1.82M)(1.61M)695.93K(6.77M)[{"date":"2019-12-31","value":-492.12,"profit":false},{"date":"2020-12-31","value":-262.19,"profit":false},{"date":"2021-12-31","value":-231.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-972.53,"profit":false}]
Income From Continuous Operations(3.42M)(1.82M)(1.61M)(1.48M)(6.51M)[{"date":"2019-12-31","value":-342481100,"profit":false},{"date":"2020-12-31","value":-182469000,"profit":false},{"date":"2021-12-31","value":-161068500,"profit":false},{"date":"2022-12-31","value":-148462000,"profit":false},{"date":"2023-12-31","value":-650538600,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(3.42M)(1.82M)(1.61M)695.93K(8.95M)[{"date":"2019-12-31","value":-492.12,"profit":false},{"date":"2020-12-31","value":-262.19,"profit":false},{"date":"2021-12-31","value":-231.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1285.86,"profit":false}]
EPS (Diluted)(0.47)(121.89)(0.34)(0.42)(10.46)[{"date":"2019-12-31","value":-47,"profit":false},{"date":"2020-12-31","value":-12189.09,"profit":false},{"date":"2021-12-31","value":-34,"profit":false},{"date":"2022-12-31","value":-42,"profit":false},{"date":"2023-12-31","value":-1046,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BBLG
Cash Ratio 13.04
Current Ratio 14.87

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BBLG
ROA (LTM) -57.25%
ROE (LTM) -119.03%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BBLG
Debt Ratio Lower is generally better. Negative is bad. 0.07
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.93

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BBLG
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.81
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.13
PEG NM

FAQs

What is Bone Biologics Corp share price today?

Bone Biologics Corp (BBLG) share price today is $1.165

Can Indians buy Bone Biologics Corp shares?

Yes, Indians can buy shares of Bone Biologics Corp (BBLG) on Vested. To buy Bone Biologics Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BBLG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bone Biologics Corp be purchased?

Yes, you can purchase fractional shares of Bone Biologics Corp (BBLG) via the Vested app. You can start investing in Bone Biologics Corp (BBLG) with a minimum investment of $1.

How to invest in Bone Biologics Corp shares from India?

You can invest in shares of Bone Biologics Corp (BBLG) via Vested in three simple steps:

  • Click on Sign Up or Invest in BBLG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bone Biologics Corp shares
What is Bone Biologics Corp 52-week high and low stock price?

The 52-week high price of Bone Biologics Corp (BBLG) is $6.34. The 52-week low price of Bone Biologics Corp (BBLG) is $0.8.

What is Bone Biologics Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bone Biologics Corp (BBLG) is

What is Bone Biologics Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bone Biologics Corp (BBLG) is 0.81

What is Bone Biologics Corp dividend yield?

The dividend yield of Bone Biologics Corp (BBLG) is 0.00%

What is the Market Cap of Bone Biologics Corp?

The market capitalization of Bone Biologics Corp (BBLG) is $3.13M

What is Bone Biologics Corp’s stock symbol?

The stock symbol (or ticker) of Bone Biologics Corp is BBLG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top